Brainstorm Historical Income Statement
| BCLI Stock | USD 1.74 0.12 7.41% |
Historical analysis of Brainstorm Cell income statement accounts such as Interest Expense of 515 K, Selling General Administrative of 11.2 M or Total Revenue of 0.0 can show how well Brainstorm Cell Therapeutics performed in making a profits. Evaluating Brainstorm Cell income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Brainstorm Cell's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Brainstorm Cell Ther latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Brainstorm Cell Ther is a good buy for the upcoming year.
Brainstorm |
About Brainstorm Income Statement Analysis
Brainstorm Cell Ther Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Brainstorm Cell shareholders. The income statement also shows Brainstorm investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Brainstorm Cell Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Brainstorm Cell Ther. It is also known as Brainstorm Cell overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Brainstorm Cell's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Brainstorm Cell Ther current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. As of now, Brainstorm Cell's Other Operating Expenses is increasing as compared to previous years. The Brainstorm Cell's current Cost Of Revenue is estimated to increase to about 278.2 K, while Gross Profit is forecasted to increase to (251.8 K).
Brainstorm Cell income statement Correlations
Click cells to compare fundamentals
Brainstorm Cell Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Brainstorm Cell income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 164K | 219K | 260K | 285K | 265K | 304.4K | |
| Interest Expense | 252K | 127K | 82K | 545K | 490.5K | 515.0K | |
| Selling General Administrative | 5.8M | 9.4M | 9.3M | 10.9M | 10.7M | 11.2M | |
| Gross Profit | (732K) | (219K) | (260K) | (285K) | (265K) | (251.8K) | |
| Other Operating Expenses | 23.0M | 31.7M | 24.5M | 24.8M | 21.4M | 22.5M | |
| Operating Income | (23.0M) | (31.7M) | (24.5M) | (24.8M) | (21.4M) | (20.4M) | |
| Ebit | (23.0M) | (31.7M) | (24.5M) | (24.8M) | (17.2M) | (16.3M) | |
| Ebitda | (22.8M) | (31.5M) | (24.3M) | (24.5M) | (16.9M) | (16.1M) | |
| Cost Of Revenue | 366K | 219K | 260K | 285K | 265K | 278.3K | |
| Total Operating Expenses | 23.0M | 31.7M | 24.5M | 24.8M | 21.2M | 22.2M | |
| Income Before Tax | (23.3M) | (31.8M) | (24.5M) | (24.3M) | (17.2M) | (16.3M) | |
| Total Other Income Expense Net | (252K) | (127K) | 82K | 545K | 4.2M | 4.5M | |
| Net Income | (23.5M) | (31.9M) | (24.4M) | (23.7M) | (17.2M) | (16.3M) | |
| Income Tax Expense | 252K | 127K | (82K) | (545K) | (490.5K) | (466.0K) | |
| Research Development | 17.2M | 22.3M | 15.2M | 14.0M | 10.5M | 7.1M | |
| Net Income From Continuing Ops | (23.3M) | (31.8M) | (24.5M) | (24.3M) | (16.6M) | (17.5M) | |
| Net Income Applicable To Common Shares | (23.3M) | (31.8M) | (24.5M) | (24.3M) | (21.8M) | (20.8M) | |
| Interest Income | 115K | 252K | 82K | 545K | 626.8K | 658.1K | |
| Net Interest Income | (252K) | (127K) | 82K | 545K | (12K) | (11.4K) | |
| Reconciled Depreciation | 164K | 219K | 260K | 285K | 269K | 218.7K |
Currently Active Assets on Macroaxis
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.45) | Return On Assets (1.78) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.